| |
|
|
|
Fulgent Genetics Inc  
|
|
17.42 1.36 (0.08%) |
05-29 16:00 |
|
Open: |
16.7 |
Pre close: |
16.06 |
Target:
|
20.11
|
|
High: |
18 |
Low: |
16.2532 |
Resistance:
|
17.22
20.11
|
|
Volume: |
481,069 |
Market Cap: |
378M |
Support:
|
11.55
 8.05
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
15.52
|
MACD |
MACD(12,26):
|
1.06 |
|
MA(20): |
12.45 |
Signal(12,26,9): |
0.45 |
|
MA(100): |
13.50 |
Stochastic Oscillator |
%K(14,3):
|
87.42 |
|
MA(250): |
10.78 |
%D(3): |
85.54 |
|
Average Volume(K) |
3-Month: |
35455
|
52-Week |
High:
|
20.60 |
|
10-Days: |
33252 |
Low: |
4.71 |
|
RSI |
RSI(14):
|
63.58 |
Change(%): |
145.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.020 |
Return on Equity (ttm) |
-0.1 |
Shares Out. (M) |
18.71 |
|
EPS Est. Current Year |
0.140 |
Return on Assets (ttm) |
-0.1 |
Shares Float (M) |
11.52 |
|
EPS Est. Next Year |
0.320 |
PEG Ratio |
757.27 |
% Held by Insiders |
58.51 |
|
EPS Est. Next Quarter |
0.070 |
Qtrly Rev. Growth |
47.8 |
% Held by Institutions |
58.85 |
|
Forward EPS |
-0.020 |
Gross Profit (p.s.) |
0.985 |
Shares Short (K) |
366 |
|
Book Value (p.s.) |
4.424 |
EBITDA (p.s.) |
0.095 |
P/E |
-809.50 |
|
Sales Per Share |
1.739 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.66 |
|
Profit Margin |
-0.26 |
Operating Cash Flow
(M) |
5.52 |
P/S |
9.31 |
|
Operating Margin |
-0.24 |
Levered Free Cash Flow
(M) |
4.34 |
P/CF |
54.90 |
|
|
|
|
|
|
